Karen Fusaro

Karen Fusaro currently serves as SVP of Clinical Development at Altesa BioSciences, Inc. since November 2024. Previously, Karen held the position of SVP of Clinical Operations at Seelos Therapeutics, Inc., where responsibilities included overseeing clinical and operational activities for multiple CNS indications such as Major Depression, ALS, Alzheimer's Disease, and Spinocerebellar Ataxia from September 2022 to October 2024. Karen's extensive industry experience also includes roles as SVP of Clinical Operations at Antios Therapeutics, Vice President at Melinta Therapeutics, Senior Director at The Medicines Company, Associate Director at Purdue Pharma and Novartis, and Assistant Director at GlaxoSmithKline, where clinical programs in Infectious Diseases were managed. Karen began the career as Lead CRA at Lineberry Research Associates after completing studies at Binghamton University from 1991 to 1995.